Open access
Jun 2026
Cost effectiveness and public health impact of PCV20 among adults in France.
PCV20 is a cost-saving alternative to the PCV13 → PPV23 sequence for at-risk adults in France and provides substantial public health gains and represents a highly cost-effective strategy relative to commonly cited French vaccine HTA benchmarks.
S. Fiévez, Mélanie Menara, E. Blanc et al.
· BMC Public Health · 0 citations